Betty Shum
Pediatric Endocrinology · Madera, CANPI 1912392945
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $786, 6.7 times the $118 reported in 2021.
Across 98 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$369
- Neurocrine Biosciences, Inc.$289
- Ascendis Pharma Endocrinology Inc$148
- Xeris Pharmaceuticals, Inc.$143
- Sanofi-aventis U.S. LLC$136
- Ultragenyx Pharmaceutical Inc.$130
- plus $897 from 17 others
What the payments were for
- Food & beverage$2,112100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $369 |
| Neurocrine Biosciences, Inc. | 6 | $289 |
| Ascendis Pharma Endocrinology Inc | 7 | $148 |
| Xeris Pharmaceuticals, Inc. | 8 | $143 |
| Sanofi-aventis U.S. LLC | 3 | $136 |
| Ultragenyx Pharmaceutical Inc. | 7 | $130 |
| Pfizer | 6 | $130 |
| Abbott | 6 | $118 |
| Novo Nordisk | 5 | $110 |
| Medtronic | 5 | $104 |
| Kyowa Kirin, Inc. | 3 | $61 |
| Cequr Corporation | 1 | $55 |
| Dexcom, Inc. | 2 | $45 |
| Mannkind Corporation | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Tandem Diabetes Care, Inc. | 2 | $38 |
| Rhythm Pharmaceuticals, Inc. | 1 | $27 |
| Tolmar, Inc. | 1 | $27 |
| AstraZeneca | 1 | $25 |
| Neurelis, Inc. | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Cranial Technologies, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRENESSITY$154
- TZIELD$106
How this compares
$2,112 in reported general payments places this provider in the 60th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Madera
- Jarreau Spencer ChenMadera$5K
- Omar AliMadera$5K
- Meenal MendirattaMadera$3K
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Lynda PolgreenOrange$167K
- Kevin KaisermanWest Covina$150K
- Amrit BhangooLong Beach$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.